• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
A photo finish at a horse race with both horses crossing the finish line
Pharma

Pfizer, Arvinas' breast cancer med wins FDA approval

Pfizer and Arvinas will leave commercialization of the drug to a yet-to-be-identified partner, the companies have said.
Zoey Becker May 1, 2026 3:50pm
Go sign green light

Axsome's Auvelity wins FDA expansion for Alzheimer's agitation

May 1, 2026 11:42am
MA mergers and acquisitions deal handshake buyout

Esperion to go private in potential $1.1B buyout by ArchiMed

May 1, 2026 11:26am
Samsung

Samsung Biologics' labor union holds general strike

May 1, 2026 11:00am
Stock market drop

Summit shares tumble on interim PD-1/VEGF trial miss

May 1, 2026 10:56am
FDA

FDA clarifies Form 483 expectations after production inspections

May 1, 2026 10:52am
More News

Regulatory tracker: AZ's Truqap clears FDA expert panel vote

May 1, 2026 9:23am

Sun-Organon, Astellas, BeOne—Fierce Pharma Asia

May 1, 2026 8:43am

 A pivotal time for an RNA pioneer 

May 1, 2026 8:30am

Repatha helps Amgen overcome Prolia's LOE freefall in Q1

May 1, 2026 8:18am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings